Xuerong Wang

4.5k citations

96 papers · 3.5k indexed · 1 hit paper · h-index 34

Co-authors: Fadlo R. Khuri Ping Yue Haian Fu Shi-Yong Sun Zhongmei Zhou Laura M. Rosenberg Shi‐Yong Sun Baoan Chen
Topics: PI3K/AKT/mTOR signaling in cancer (14 papers)Cancer Mechanisms and Therapy (9 papers)RNA modifications and cancer (7 papers)
Cited by: Cancer Research Molecular Biology Pathology and Forensic Medicine
Journals: Journal of Biological Chemistry Journal of Clinical InvestigationSHILAP Revista de lepidopterología
Partner nations: China United States Hong Kong

In The Last Decade

Xuerong Wang

89 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition

2005 682 citations Xuerong Wang, Ping Yue et al. Cancer Research profile →

Peers

Countries citing papers authored by Xuerong Wang

Since Specialization

Citations

This map shows the geographic impact of Xuerong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuerong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuerong Wang more than expected).

Fields of papers citing papers by Xuerong Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuerong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuerong Wang. The network helps show where Xuerong Wang may publish in the future.

Co-authorship network of co-authors of Xuerong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuerong Wang. A scholar is included among the top collaborators of Xuerong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuerong Wang. Xuerong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	β-Hydroxybutyrate aggravates LPS-induced inflammatory response in bovine endometrial epithelial cells by activating the oxidative stress/NF-κB signaling pathway 2025 ·International Immunopharmacology ·(unknown),Fengbo Wang,(unknown),Xuerong Wang,Haisen Zhang,(unknown),Aihua Wang,(unknown),Huatao Chen	0
2	Genome‐scale CRISPR–Cas9 screen identifies PAICS as a therapeutic target for EGFR wild‐type non‐small cell lung cancer 2024 ·SHILAP Revista de lepidopterología ·Yufeng Li,(unknown),(unknown),Hongrui Zheng,Ziyi Hu,(unknown),(unknown),Tingting Zhou,(unknown),Hongshuai Wu,Xuerong Wang,Jing Wang,Fan Lin,Hua Shen	7
3	Clinical application of bronchoalveolar lavage fluid metagenomics next-generation sequencing in cancer patients with severe pneumonia 2024 ·Respiratory Research ·Chao Wang,(unknown),(unknown),(unknown),(unknown),Nan Ma,Yuepeng Cao,(unknown),(unknown),Lin Xu,Xuerong Wang	8
4	Crosstalk between Interleukin-1 Receptor-Like 1 and Transforming Growth Factor-β Receptor Signaling Promotes Renal Fibrosis 2023 ·American Journal Of Pathology ·Xingxing Zhu,Jiahui Lü,Jia Rao,(unknown),(unknown),Dongyan Shi,Kelei Cao,Shuang Wen,Chunsun Dai,Xuerong Wang,Wen‐Li Mi,Lixin Liu,Hong Zhou	9
5	Exosomes from tubular epithelial cells undergoing epithelial‐to‐mesenchymal transition promote renal fibrosis by M1 macrophage activation 2023 ·FASEB BioAdvances ·(unknown),Rui Zhang,(unknown),Xuerong Wang,(unknown),(unknown)	13
6	A novel synthesized prodrug of gemcitabine based on oxygen-free radical sensitivity inhibited the growth of lung cancer cells 2023 ·Journal of Biomedical Research ·(unknown),Yuting Meng,Wei Ge,Juan Wang,Fei Li,Xue Jun Wang,Xuerong Wang	1
7	Targeting BET proteins inhibited the growth of non‐small cell lung carcinoma through downregulation of Met expression 2022 ·Cell Biology International ·Ting Yuan,Ping Ni,Zuhao Zhang,Dandan Wu,Geng Sun,Haijun Zhang,Baoan Chen,Xuerong Wang,Zhixiang Cheng	2
8	Factors affecting the outcome of full pulpotomy in permanent posterior teeth diagnosed with reversible or irreversible pulpitis 2022 ·Scientific Reports ·Min Zhang,(unknown),Xuerong Wang,(unknown),Yixin Cai,(unknown),Chengfei Zhang,(unknown)	11
9	Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression 2022 ·Cancer Letters ·(unknown),Zhao Li,Yuting Meng,(unknown),(unknown),Quanli Zhang,Chao Wang,Fan Lin,Baoan Chen,Lin Xu,Wenbin Huang,Jing Chen,Xuerong Wang	24
10	Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma 2019 ·Molecular Cancer Therapeutics ·Kexin Xu,Geng Sun,Min Li,(unknown),(unknown),(unknown),Ping Li,Lin Xu,Wenbin Huang,Xuerong Wang	25
11	Analysis of risk factors related to patients with Sagliker syndrome 2015 ·Haiyan Wang,Guiling Liu,Wang Ju,(unknown),(unknown),Huai Li,Dandan Li,Xuerong Wang,(unknown),(unknown),Sheng‐Xue Xie,(unknown)	1
12	Multiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36 2012 ·Journal of Lipid Research ·Andrew N. Carley,Jian Bi,Xuerong Wang,Natasha H. Banke,Jason R.B. Dyck,J. Michael O’Donnell,E. Douglas Lewandowski	29
13	Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy 2009 ·Cancer Research ·Lei Fu,Young‐Ae Kim,Xuerong Wang,Xiaoyun Wu,Ping Yue,Sagar Lonial,Fadlo R. Khuri,Shi‐Yong Sun	129
14	Enhancing mTOR-targeted cancer therapy 2009 ·Expert Opinion on Therapeutic Targets ·Xuerong Wang,Shi‐Yong Sun	48
15	Enhancing Mammalian Target of Rapamycin (mTOR)–Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation 2008 ·Cancer Research ·Xuerong Wang,Ping Yue,Young Ae Kim,Haian Fu,Fadlo R. Khuri,Shi‐Yong Sun	135
16	The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway 2007 ·Molecular Cancer Therapeutics ·Heath A. Elrod,Yidan Lin,Ping Yue,Xuerong Wang,Sagar Lonial,Fadlo R. Khuri,Shi‐Yong Sun	79
17	NF-κB-Inducing Kinase Regulates Cyclooxygenase 2 Gene Expression in Macrophages by Phosphorylation of PU.1 2007 ·The Journal of Immunology ·Anser C. Azim,Xuerong Wang,Gye Young Park,Ruxana T. Sadikot,Hongmei Cao,Biji Mathew,Michael L. Atchison,Richard B. van Breemen,Myungsoo Joo,John W. Christman	12
18	[Study of matrine's use on the reversion of obtained multi-drug resistance of mice S80 tumour cell]. 2006 ·PubMed ·(unknown),Mei Wang,(unknown),Xuerong Wang,Xiaojing Li,(unknown)	2
19	[The interference in correlated molecular mechanism obtained multi-drug resistance of mouse S180's tumour cell for different alkaloid]. 2005 ·PubMed ·(unknown),(unknown),(unknown),(unknown),Xuerong Wang	1
20	[The effect of matrine on the expression of P170 LRP and TOPO II of obtained multi-drug resistance of mouse S180's tumour cell]. 2004 ·PubMed ·(unknown),Ning Wang,(unknown),Xuerong Wang,Xiaojing Li,(unknown)	5

About Xuerong Wang

Xuerong Wang is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 96 papers that have together received 3.5k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (14 papers), Cancer Mechanisms and Therapy (9 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (601 citations), Molecular Biology (2.3k citations) and Pathology and Forensic Medicine (392 citations). Xuerong Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Fadlo R. Khuri, Ping Yue, Haian Fu, Shi-Yong Sun, Zhongmei Zhou, Laura M. Rosenberg, Shi‐Yong Sun, Baoan Chen, Sulan Zhai and Sagar Lonial. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact